AD-linked R47H- TREM2 mutation induces disease-enhancing proinflammatory microglial states in mice and humans
Faten A. Sayed,Lay Kodama,Joe C. Udeochu,Li Fan,Gillian K. Carling,David Le,Qingyun Li,Lu Zhou,Hansruedi Mathys,Minghui Wang,Xiang Niu,Linas Mazutis,Xueqiao Jiang,Xueting Wang,Man Ying Wong,Fuying Gao,Maria Telpoukhovskaia,Tara E. Tracy,Georgia Frost,Yungui Zhou,Yaqiao Li,Matthew Brendel,Yue Qiu,Zuolin Cheng,Guoqiang Yu,John Hardy,Giovanni Coppola,Shiaoching Gong,Fei Wang,Michael A. DeTure,Bin Zhang,Lei Xie,Dennis W. Dickson,Wenjie Luo,Li Gan
DOI: https://doi.org/10.1101/2020.07.24.218719
2020-01-01
Abstract:The hemizygous R47H variant of , a microglia-specific gene in the brain, increases risk for late-onset Alzheimer’s disease (AD). In this study, we identified a subpopulation of microglia with disease-enhancing proinflammatory signatures associated with the R47H mutation in human AD brains and tauopathy mouse brains. Using transcriptomic analysis at the single-nuclei level from AD patients with the R47H or the common variant (CV with matched sex, pathology and status, we found that the R47H mutation was associated with cell type- and sex-specific transcriptional changes in human AD brains, with microglia exhibiting the most robust alterations. Further characterization revealed that R47H-associated microglial subpopulations had enhanced inflammatory signatures including hyperactivation of Akt, one of the signaling pathways downstream of TREM2. In a newly-generated tauopathy knock-in mouse model expressing one allele of human ( with either the R47H mutation or CV, R47H induced and exacerbated tau-mediated spatial memory deficits in female mice. Single-cell transcriptomic analysis of microglia from these mice also revealed transcriptomic changes induced by R47H that had significant overlaps with R47H microglia in human AD brains, including robust increases in proinflammatory cytokines, activation of Syk-Akt-signaling, and elevation of a subset of disease-associated microglial signatures. Strikingly, pharmacological Akt inhibition largely reversed the enhanced inflammatory signatures induced by R47H in primary microglia treated with tau fibrils. By unraveling the disease-enhancing properties of the R47H mutation in mouse and human, our findings shed light on an immune-linked AD subtype and provide new directions for modulating microglial immune responses to treat AD.